These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 17300287

  • 1. A double-blind, randomized, placebo-controlled trial of itopride (100 and 200 mg three times daily) on gastric motor and sensory function in healthy volunteers.
    Choung RS, Talley NJ, Peterson J, Camilleri M, Burton D, Harmsen WS, Zinsmeister AR.
    Neurogastroenterol Motil; 2007 Mar; 19(3):180-7. PubMed ID: 17300287
    [Abstract] [Full Text] [Related]

  • 2. Effect of a cannabinoid agonist on gastrointestinal transit and postprandial satiation in healthy human subjects: a randomized, placebo-controlled study.
    Esfandyari T, Camilleri M, Ferber I, Burton D, Baxter K, Zinsmeister AR.
    Neurogastroenterol Motil; 2006 Sep; 18(9):831-8. PubMed ID: 16918762
    [Abstract] [Full Text] [Related]

  • 3. Effect of itopride on gastric emptying in longstanding diabetes mellitus.
    Stevens JE, Russo A, Maddox AF, Rayner CK, Phillips L, Talley NJ, Giguère M, Horowitz M, Jones KL.
    Neurogastroenterol Motil; 2008 May; 20(5):456-63. PubMed ID: 18179609
    [Abstract] [Full Text] [Related]

  • 4. Effect of oral CCK-1 agonist GI181771X on fasting and postprandial gastric functions in healthy volunteers.
    Castillo EJ, Delgado-Aros S, Camilleri M, Burton D, Stephens D, O'Connor-Semmes R, Walker A, Shachoy-Clark A, Zinsmeister AR.
    Am J Physiol Gastrointest Liver Physiol; 2004 Aug; 287(2):G363-9. PubMed ID: 15246968
    [Abstract] [Full Text] [Related]

  • 5. The effect of short-term, low-dose tricyclic and tetracyclic antidepressant treatment on satiation, postnutrient load gastrointestinal symptoms and gastric emptying: a double-blind, randomized, placebo-controlled trial.
    Choung RS, Cremonini F, Thapa P, Zinsmeister AR, Talley NJ.
    Neurogastroenterol Motil; 2008 Mar; 20(3):220-7. PubMed ID: 18031471
    [Abstract] [Full Text] [Related]

  • 6. Gastric sensory and motor dysfunction in adolescents with functional dyspepsia.
    Chitkara DK, Camilleri M, Zinsmeister AR, Burton D, El-Youssef M, Freese D, Walker L, Stephens D.
    J Pediatr; 2005 Apr; 146(4):500-5. PubMed ID: 15812453
    [Abstract] [Full Text] [Related]

  • 7. Influence of itopride and domperidone on gastric tone and on the perception of gastric distention in healthy subjects.
    Van den Houte K, Carbone F, Pauwels A, Vos R, Vanuytsel T, Tack J.
    Neurogastroenterol Motil; 2019 Apr; 31(4):e13544. PubMed ID: 30706652
    [Abstract] [Full Text] [Related]

  • 8. A placebo-controlled trial of itopride in functional dyspepsia.
    Holtmann G, Talley NJ, Liebregts T, Adam B, Parow C.
    N Engl J Med; 2006 Feb 23; 354(8):832-40. PubMed ID: 16495395
    [Abstract] [Full Text] [Related]

  • 9. Effect of somatostatin analog on postprandial satiation in obesity.
    Cremonini F, Camilleri M, Gonenne J, Stephens D, Oenning L, Baxter K, Foxx-Orenstein A, Burton D.
    Obes Res; 2005 Sep 23; 13(9):1572-9. PubMed ID: 16222060
    [Abstract] [Full Text] [Related]

  • 10. Double-blind, randomized, placebo-controlled study to evaluate the effects of tegaserod on gastric motor, sensory and myoelectric function in healthy volunteers.
    Talley NJ, Camilleri M, Burton D, Thomforde G, Koch K, Rucker MJ, Peterson J, Zinsmeister AR, Earnest DL.
    Aliment Pharmacol Ther; 2006 Sep 01; 24(5):859-67. PubMed ID: 16918891
    [Abstract] [Full Text] [Related]

  • 11. Clinical trial: effects of tegaserod on gastric motor and sensory function in patients with functional dyspepsia.
    Thumshirn M, Fruehauf H, Stutz B, Tougas G, Salter J, Fried M.
    Aliment Pharmacol Ther; 2007 Nov 15; 26(10):1399-407. PubMed ID: 17892526
    [Abstract] [Full Text] [Related]

  • 12. A dose-ranging, placebo-controlled, pilot trial of Acotiamide in patients with functional dyspepsia.
    Tack J, Masclee A, Heading R, Berstad A, Piessevaux H, Popiela T, Vandenberghe A, Kato H.
    Neurogastroenterol Motil; 2009 Mar 15; 21(3):272-80. PubMed ID: 19254354
    [Abstract] [Full Text] [Related]

  • 13. Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials.
    Talley NJ, Tack J, Ptak T, Gupta R, Giguère M.
    Gut; 2008 Jun 15; 57(6):740-6. PubMed ID: 17965059
    [Abstract] [Full Text] [Related]

  • 14. Stimulatory action of itopride hydrochloride on colonic motor activity in vitro and in vivo.
    Tsubouchi T, Saito T, Mizutani F, Yamauchi T, Iwanaga Y.
    J Pharmacol Exp Ther; 2003 Aug 15; 306(2):787-93. PubMed ID: 12724347
    [Abstract] [Full Text] [Related]

  • 15. Acotiamide hydrochloride (Z-338), a new selective acetylcholinesterase inhibitor, enhances gastric motility without prolonging QT interval in dogs: comparison with cisapride, itopride, and mosapride.
    Matsunaga Y, Tanaka T, Yoshinaga K, Ueki S, Hori Y, Eta R, Kawabata Y, Yoshii K, Yoshida K, Matsumura T, Furuta S, Takei M, Tack J, Itoh Z.
    J Pharmacol Exp Ther; 2011 Mar 15; 336(3):791-800. PubMed ID: 21123674
    [Abstract] [Full Text] [Related]

  • 16. Effect of a proton pump inhibitor on postprandial gastric volume, emptying and symptoms in healthy human subjects: a pilot study.
    Grudell AB, Camilleri M, Burton DD, Stephens DA.
    Aliment Pharmacol Ther; 2006 Oct 01; 24(7):1037-43. PubMed ID: 16984497
    [Abstract] [Full Text] [Related]

  • 17. Alteration of gastric functions and candidate genes associated with weight reduction in response to sibutramine.
    Vazquez Roque MI, Camilleri M, Clark MM, Tepoel DA, Jensen MD, Graszer KM, Kalsy SA, Burton DD, Baxter KL, Zinsmeister AR.
    Clin Gastroenterol Hepatol; 2007 Jul 01; 5(7):829-37. PubMed ID: 17544870
    [Abstract] [Full Text] [Related]

  • 18. Effects of cilomilast, a selective phosphodiesterase 4 inhibitor, on esophageal motility and pH, and orocecal and colonic transit: two single-center, randomized, double-blind, placebo-controlled, two-part crossover studies in healthy volunteers.
    Houghton LA, Atkinson W, Whorwell PJ, Morris J, Murdoch RD, Cooper SM, Webber DM, Walls CM.
    Clin Ther; 2006 Apr 01; 28(4):569-81. PubMed ID: 16750468
    [Abstract] [Full Text] [Related]

  • 19. A placebo-controlled trial of the 5-HT1A agonist R-137696 on symptoms, visceral hypersensitivity and on impaired accommodation in functional dyspepsia.
    Tack J, Van Den Elzen B, Tytgat G, Wajs E, Van Nueten L, De Ridder F, Boeckxstaens G.
    Neurogastroenterol Motil; 2009 Jun 01; 21(6):619-26, e23-4. PubMed ID: 19220756
    [Abstract] [Full Text] [Related]

  • 20. Effects of amitriptyline on gastric sensorimotor function and postprandial symptoms in healthy individuals: a randomized, double-blind, placebo-controlled trial.
    Bouras EP, Talley NJ, Camilleri M, Burton DD, Heckman MG, Crook JE, Richelson E.
    Am J Gastroenterol; 2008 Aug 01; 103(8):2043-50. PubMed ID: 18803000
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.